Ribonucleotide Reductase Inhibitors and Future Drug Design

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|6|5|409-431

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.6, Iss.5, 2006-08, pp. : 409-431

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radical Scavengers as Ribonucleotide Reductase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 24, 2012-01 ,pp. : 2827-2842

Bentham Science Publishers

Access to resources Recommend Favorite

Ribonucleotide Reductase: A Mechanistic Portrait of Substrate Analogues Inhibitors

By  

Current Medicinal Chemistry, Vol. 17, Iss. 26, 2010-09 ,pp. : 2854-2872

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Ribonucleotide Reductase Inhibitors: A Review on Structure Activity Relationships

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 13, 2013-11 ,pp. : 1862-1872

Bentham Science Publishers

Access to resources Recommend Favorite

Overview of Ribonucleotide Reductase Inhibitors: An Appealing Target in Anti-Tumour Therapy

By  

Current Medicinal Chemistry, Vol. 12, Iss. 11, 2005-06 ,pp. : 1283-1294

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and biological evaluation of O-alkylated tropolones and related -ketohydroxy derivatives as ribonucleotide reductase inhibitors

By Tamburlin-Thumin I.   Crozet M.P.   Barriere J.-C.   Barreau M.   Riou J.-F.   Lavelle F.  

European Journal of Medicinal Chemistry, Vol. 36, Iss. 6, 2001-06 ,pp. : 561-568

Elsevier

Access to resources Recommend Favorite